Prevention of cancer by prophylactic human papillomavirus vaccines

被引：24

作者：

Kwak, Kihyuck ^{[1
]}

Yemelyanova, Anna ^{[1
]}

Roden, Richard B. S. ^{[1
,2
,3
]}

机构：

[1] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21231 USA

[2] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21231 USA

[3] Johns Hopkins Univ, Dept Gynecol & Obstet, Baltimore, MD 21231 USA

来源：

CURRENT OPINION IN IMMUNOLOGY | 2011年 / 23卷 / 02期

基金：

美国国家卫生研究院;

关键词：

VIRUS-LIKE PARTICLES; MINOR CAPSID PROTEIN; ANTIBODY-RESPONSES; IMMUNE-RESPONSES; FUSION PROTEIN; DOUBLE-BLIND; YOUNG-WOMEN; L1; PROTEIN; HPV TYPES; B-CELL;

D O I：

10.1016/j.coi.2010.11.009

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Oncogenic human papillomaviruses (HPVs) are exclusively mucosal pathogens that are noncytopathic and the basal epithelial cells harboring and maintaining an infection do not produce either capsid antigen or virus. The efficacy of the licensed L1 virus-like particle (VLP) vaccines has encouraged development of several second generation vaccines aimed at expanding the coverage to all oncogenic HPV types and reducing barriers to global implementation. Currently there is no defined immune correlate of protection that can be used to determine if an individual patient is protected and for the evaluation of these second generation vaccines. Surprisingly, passive transfer of neutralizing serum antibody is protective in animal models. Recent studies suggest how neutralizing antibody mediates immunity against mucosal HPV and the possible impact of memory B cells.

引用

页码：244 / 251

页数：8

共 53 条

[1] THE INFLUENCE OF ANTIGEN ORGANIZATION ON B-CELL RESPONSIVENESS [J].

BACHMANN, MF ;

ROHRER, UH ;

KUNDIG, TM ;

BURKI, K ;

HENGARTNER, H ;

ZINKERNAGEL, RM .

SCIENCE, 1993, 262 (5138) :1448-1451

[2] Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments [J].

Bernard, Hans-Ulrich ;

Burk, Robert D. ;

Chen, Zigui ;

van Doorslaer, Koenraad ;

zur Hausen, Harald ;

de Villiers, Ethel-Michele .

VIROLOGY, 2010, 401 (01) :70-79

[3] IMMUNIZATION WITH VIRUS-LIKE PARTICLES FROM COTTONTAIL RABBIT PAPILLOMAVIRUS (CRPV) CAN PROTECT AGAINST EXPERIMENTAL CRPV INFECTION [J].

BREITBURD, F ;

KIRNBAUER, R ;

HUBBERT, NL ;

NONNENMACHER, B ;

TRINDINHDESMARQUET, C ;

ORTH, G ;

SCHILLER, JT ;

LOWY, DR .

JOURNAL OF VIROLOGY, 1995, 69 (06) :3959-3963

[4] The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years [J].

Brown, Darron R. ;

Kjaer, Susanne K. ;

Sigurdsson, Kristjan ;

Iversen, Ole-Erik ;

Hernandez-Avila, Mauricio ;

Wheeler, Cosette M. ;

Perez, Gonzalo ;

Koutsky, Laura A. ;

Tay, Eng Hseon ;

Garcia, Patricia ;

Ault, Kevin A. ;

Garland, Suzanne M. ;

Leodolter, Sepp ;

Olsson, Sven-Eric ;

Tang, Grace W. K. ;

Ferris, Daron G. ;

Paavonen, Jorma ;

Steben, Marc ;

Bosch, F. Xavier ;

Dillner, Joakim ;

Joura, Elmar A. ;

Kurman, Robert J. ;

Majewski, Slawomir ;

Munoz, Nubia ;

Myers, Evan R. ;

Villa, Luisa L. ;

Taddeo, Frank J. ;

Roberts, Christine ;

Tadesse, Amha ;

Bryan, Janine ;

Lupinacci, Lisa C. ;

Giacoletti, Katherine E. D. ;

Sings, Heather L. ;

James, Margaret ;

Hesley, Teresa M. ;

Barra, Eliav .

JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (07) :926-935

[5] Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma [J].

Cantarella, Giuseppina ;

Liniger, Matthias ;

Zuniga, Armando ;

Schiller, John T. ;

Billeter, Martin ;

Naim, Hussein Y. ;

Glueck, Reinhard .

VACCINE, 2009, 27 (25-26) :3385-3390

[6] Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16 [J].

Chen, XJS ;

Garcea, RL ;

Goldberg, I ;

Casini, G ;

Harrison, SC .

MOLECULAR CELL, 2000, 5 (03) :557-567

[7] Papillomavirus capsid protein expression in Escherichia coli:: Purification and assembly of HPV11 and HPV16 L1 [J].

Chen, XJS ;

Casini, G ;

Harrison, SC ;

Garcea, RL .

JOURNAL OF MOLECULAR BIOLOGY, 2001, 307 (01) :173-182

[8] POSTATTACHMENT NEUTRALIZATION OF PAPILLOMAVIRUSES BY MONOCLONAL AND POLYCLONAL ANTIBODIES [J].

CHRISTENSEN, ND ;

CLADEL, NM ;

REED, CA .

VIROLOGY, 1995, 207 (01) :136-142

[9] Characterization of the HPV-specific memory B cell and systemic antibody responses in women receiving an unadjuvanted HPV16 L1 VLP vaccine [J].

Dauner, Joseph G. ;

Pan, Yuanji ;

Hildesheim, Allan ;

Harro, Clayton ;

Pinto, Ligia A. .

VACCINE, 2010, 28 (33) :5407-5413

[10] Mechanisms of human papillomavirus type 16 neutralization by L2 cross-neutralizing and L1 type-specific antibodies [J].

Day, Patricia M. ;

Garnbhira, Ratish ;

Roden, Richard B. S. ;

Lowy, Douglas R. ;

Schiller, John T. .

JOURNAL OF VIROLOGY, 2008, 82 (09) :4638-4646

← 1 2 3 4 5 6 →